Advertisement
At close: 04:00PM EST
After hours:
| Previous Close | 1.7100 |
| Open | 1.7300 |
| Bid | 1.8500 x 100 |
| Ask | 1.9200 x 100 |
| Day's Range | 1.6900 - 1.8884 |
| 52 Week Range | 0.3500 - 4.6400 |
| Volume | |
| Avg. Volume | 122,142 |
| Market Cap | 93.055M |
| Beta (5Y Monthly) | -393,982.88 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.5300 |
| Earnings Date | Nov 06, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 6.04 |
GuruFocus.comMDxHealth SA (MDXH) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Raised Guidance ...
MDxHealth SA (MDXH) reports a 21% revenue increase and raises 2024 guidance, while addressing margin pressures and strategic growth opportunities.
GlobeNewswireMDxHealth Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2024
Tissue-based test volumes increase by 36%, liquid-based test volumes by 24% Company raises 2024 revenue guidance to $87-89 million, representing 25% growth Pro-forma cash of $53.5 million Conference call and webcast today at 4:30pm ET IRVINE, CA – November 6, 2024 (GlobeNewswire) – MDxHealth SA (NASDAQ: MDXH) (the "Company" or "mdxhealth"), a leading precision diagnostics company, today announced its financial results for the third quarter and nine-month period ended September 30, 2024. Michael
Advertisement
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.